hit counter

Alzheimer’s Fingerprick Blood Biomarkers: p-tau217 and GFAP Track Cognition

MHD featured image for Alzheimer’s disease fingerprick blood biomarkers p-tau217 and GFAP.

A 2026 PROTECT study involving 174 older adults found that self-administered fingerprick p-tau217 correlated with episodic memory (r = 0.299, p < 0.001) and GFAP correlated with working memory (r = 0.183, p = 0.034), supporting remote Alzheimer's risk triage rather than a stand-alone dementia diagnosis. Research Highlights Fingerprick sampling reached 77% completion: 174 of …

Read more

Chemotherapy Neuropathy Links Pain and Chemobrain Mechanisms

MHD featured image for chemotherapy neuropathy, pain, and chemobrain mechanisms.

A 2026 neuroscience review argues that chemotherapy-induced peripheral neurotoxicity should not be treated as a purely peripheral nerve problem: CIPN affects 70-90% of patients during chemotherapy, persists chronically in 20-30% of survivors, and may interact with central sensitization, pain networks, mood, sleep, and chemobrain.1 The strongest claim is mechanistic connection, not proof that neuropathy alone …

Read more

NOS3 TT Variant Linked to 1.72x Cognitive Risk in First-Episode Depression

A 2026 cross-sectional study of 519 older adults with first-episode depression found that the NOS3 rs1799983 TT genotype was independently associated with cognitive impairment, adjusted OR 1.720 (95% CI 1.027-2.882).1 The result is strongest as a vascular-inflammation clue, not as a ready clinical genetic test. Research Highlights TT genotype carried the headline signal: in multivariable …

Read more

Antipsychotic Dose Was Not Linked to MoCA in Schizophrenia

A 2026 cross-sectional schizophrenia study found no meaningful association between antipsychotic dose and Montreal Cognitive Assessment (MoCA) performance in young, clinically stable outpatients. Cognitive scores related more strongly to symptom burden, illness duration, education, and age at diagnosis than to daily or 1-year cumulative antipsychotic exposure.1 Research Highlights Daily dose was not linked to MoCA: …

Read more

tDCS Plus Cognitive Training Improved Cognition Short-Term by SMD 0.36

MHD featured image for tDCS plus cognitive training in cognitive impairment.

A 2026 medRxiv meta-analysis of 27 trials found that transcranial direct current stimulation added to cognitive training improved global cognition immediately after treatment by SMD 0.36 compared with cognitive training alone.1 The signal was small, short-term, and rated very low certainty, so it is not evidence that tDCS is a durable cognitive-rehabilitation shortcut. Research Highlights …

Read more

Chronic Disease Linked Loneliness to Cognitive Risk

A longitudinal MIDUS analysis involving 840 adults found that loneliness scores higher than a person's objective social-isolation score were linked to later cognitive impairment mainly through chronic disease burden, while the allostatic-load pathway was weaker than the chronic-disease pathway and not statistically confirmed for the main cognitive outcomes.1 Research Highlights Loneliness was separated from isolation: …

Read more

Residual Sleepiness in Treated Sleep Apnea Linked to Memory Deficits

Stylized sleep-apnea treatment scene with CPAP, daytime sleepiness testing, and memory-task circuitry, representing cognitive deficits linked to residual sleepiness despite PAP adherence.

Some sleep apnea patients stay sleepy even when their CPAP is used 6+ hours a night and apnea events have been driven back to normal range. A 2026 cross-sectional study of 65 PAP-adherent adults found those residually sleepy patients performed measurably worse on global cognition, memory, executive function, attention, and processing speed than their well-rested …

Read more